FI119988B - Sykliset heksapeptidit, joilla on antibioottinen aktiivisuus - Google Patents

Sykliset heksapeptidit, joilla on antibioottinen aktiivisuus Download PDF

Info

Publication number
FI119988B
FI119988B FI971397A FI971397A FI119988B FI 119988 B FI119988 B FI 119988B FI 971397 A FI971397 A FI 971397A FI 971397 A FI971397 A FI 971397A FI 119988 B FI119988 B FI 119988B
Authority
FI
Finland
Prior art keywords
phenyl
alkoxy
substituted
nmr
alkyl
Prior art date
Application number
FI971397A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI971397A (fi
FI971397A0 (fi
Inventor
Hisashi Takasugi
Hidenori Ohki
Akira Yamada
Masaki Tomishima
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26305774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI119988(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB9420425A external-priority patent/GB9420425D0/en
Priority claimed from GBGB9508745.8A external-priority patent/GB9508745D0/en
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of FI971397A0 publication Critical patent/FI971397A0/fi
Publication of FI971397A publication Critical patent/FI971397A/fi
Application granted granted Critical
Publication of FI119988B publication Critical patent/FI119988B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI971397A 1994-10-07 1997-04-04 Sykliset heksapeptidit, joilla on antibioottinen aktiivisuus FI119988B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB9420425 1994-10-07
GB9420425A GB9420425D0 (en) 1994-10-07 1994-10-07 New compound
GBGB9508745.8A GB9508745D0 (en) 1995-04-28 1995-04-28 New compound
GB9508745 1995-04-28
JP9501983 1995-09-29
PCT/JP1995/001983 WO1996011210A1 (fr) 1994-10-07 1995-09-29 Hexapeptides cycliques a activite antibiotique

Publications (3)

Publication Number Publication Date
FI971397A0 FI971397A0 (fi) 1997-04-04
FI971397A FI971397A (fi) 1997-05-27
FI119988B true FI119988B (fi) 2009-05-29

Family

ID=26305774

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971397A FI119988B (fi) 1994-10-07 1997-04-04 Sykliset heksapeptidit, joilla on antibioottinen aktiivisuus

Country Status (27)

Country Link
US (2) US6107458A (fr)
EP (1) EP0788511B1 (fr)
JP (2) JP2897427B2 (fr)
KR (1) KR100353303B1 (fr)
CN (1) CN1203089C (fr)
AR (1) AR041770A1 (fr)
AT (1) ATE229541T1 (fr)
AU (1) AU696949B2 (fr)
BR (2) BRPI9504791B8 (fr)
CA (1) CA2202058C (fr)
DE (2) DE69529172T2 (fr)
DK (1) DK0788511T3 (fr)
ES (1) ES2187575T3 (fr)
FI (1) FI119988B (fr)
FR (1) FR08C0028I2 (fr)
HK (1) HK1004136A1 (fr)
HU (1) HU228151B1 (fr)
IL (1) IL115484A (fr)
LU (1) LU91452I2 (fr)
MX (1) MX9702531A (fr)
NL (1) NL300352I2 (fr)
NO (2) NO328483B1 (fr)
OA (1) OA10475A (fr)
PT (1) PT788511E (fr)
RU (1) RU2165423C2 (fr)
TR (1) TR199501229A2 (fr)
WO (1) WO1996011210A1 (fr)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696084A (en) * 1996-08-16 1997-12-09 Abbott Laboratories Amino-lipopetide antifungal agents
AUPO371596A0 (en) * 1996-11-19 1996-12-12 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPO381496A0 (en) * 1996-11-25 1996-12-19 Fujisawa Pharmaceutical Co., Ltd. New compound
EP0994101A4 (fr) * 1997-06-18 2002-05-02 Fujisawa Pharmaceutical Co Nouveau procede de preparation
AU756792B2 (en) * 1998-02-09 2003-01-23 Fujisawa Pharmaceutical Co., Ltd. New compound
KR100396737B1 (ko) * 1998-02-09 2003-09-13 후지사와 야꾸힝 고교 가부시키가이샤 신규 화합물
ATE311373T1 (de) * 1999-02-11 2005-12-15 Emisphere Tech Inc Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
US7084279B1 (en) * 1999-02-11 2006-08-01 Emisphere Technologies Inc. Oxadiazole compounds and compositions for delivering active agents
AUPP999799A0 (en) * 1999-04-27 1999-05-20 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPQ066399A0 (en) * 1999-05-31 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
AU6564000A (en) 1999-07-27 2001-02-13 Aventis Pharma Deutschland Gmbh Novel cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical
AUPQ462399A0 (en) * 1999-12-13 2000-01-13 Fujisawa Pharmaceutical Co., Ltd. New use
TWI250992B (en) * 2000-02-21 2006-03-11 Astellas Pharma Inc Polypeptide compounds for the prophylactic and/or therapeutic treatment of infectious diseases caused by pathogenic microorganisms
ES2191516B1 (es) * 2000-07-28 2005-01-01 Consejo Superior De Investigaciones Cientificas Antibioticos antifungicos de naturaleza peptidica inhibidores de la germinacion y el crecimiento de hongos fitopatogenos.
AUPQ938700A0 (en) * 2000-08-14 2000-09-07 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
JP4077320B2 (ja) 2001-01-29 2008-04-16 塩野義製薬株式会社 5−メチル−1−フェニル−2−(1h)−ピリドンを有効成分として含有する医薬製剤
JP2005053782A (ja) * 2001-08-31 2005-03-03 Fujisawa Pharmaceut Co Ltd 環状リポペプチド化合物の新規結晶
AU2003217676B2 (en) 2002-02-22 2009-06-11 Takeda Pharmaceutical Company Limited Active agent delivery systems and methods for protecting and administering active agents
US7199248B2 (en) 2002-08-08 2007-04-03 Astellas Pharma Inc. Process
AU2003903205A0 (en) * 2003-06-23 2003-07-10 Fujisawa Pharmaceutical Co., Ltd. New compound
WO2005018743A1 (fr) * 2003-07-22 2005-03-03 Theravance, Inc. Utilisation d'un agent antifongique a base d'echinocandines conjointement avec un agent antibacterien glycopeptidique
CN1845751A (zh) * 2003-09-05 2006-10-11 默克公司 固定相和利用该固定相的纯化方法
EP1669350B1 (fr) * 2003-09-22 2012-02-29 Msd K.K. Derives de piperidine
US7476673B2 (en) * 2003-12-30 2009-01-13 Allergan, Inc. Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptors
JP2007538103A (ja) * 2004-05-20 2007-12-27 ザ スクリップス リサーチ インスティテュート トランスサイレチン安定化
US8071603B2 (en) 2004-09-20 2011-12-06 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
EP1799667B1 (fr) 2004-09-20 2013-03-20 Xenon Pharmaceuticals Inc. Derives heterocycliques et leur utilisation comme agents therapeutiques
EP1814551A2 (fr) 2004-09-20 2007-08-08 Xenon Pharmaceuticals Inc. Derives de pyridazine destines a l'inhibition du desaturase-coa-stearoyl de l'humain
EP2266569A3 (fr) 2004-09-20 2011-03-09 Xenon Pharmaceuticals Inc. Dérivés hétérocycliques et leur utilisation en tant qu'inhibiteurs de la stearoyl-coa desaturase
US7592343B2 (en) 2004-09-20 2009-09-22 Xenon Pharmaceuticals Inc. Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors
TW200626592A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
MX2007003327A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos, y su uso como mediadores de estearoil-coa desaturasa.
EP2301536B1 (fr) * 2004-10-13 2014-04-09 PTC Therapeutics, Inc. Composes de suppression de non-sens et procedes de leur utilisation
EP2540296A1 (fr) 2005-06-03 2013-01-02 Xenon Pharmaceuticals Inc. Dérivés d'arminothiazole utilisés comme inhibiteurs de la stéaroyl-coa désaturase humaine
CN101282936B (zh) * 2005-10-07 2012-05-16 橘生药品工业株式会社 氮化杂环化合物及包含其的药物组合物
CN101516387B (zh) * 2006-07-26 2014-06-04 桑多斯股份公司 卡泊芬净制剂
US8853392B2 (en) 2007-06-03 2014-10-07 Vanderbilt University Benzamide mGluR5 positive allosteric modulators and methods of making and using same
ES2656100T3 (es) 2007-08-13 2018-02-23 Monsanto Technology Llc Composiciones y procedimientos de control de nemátodos
US20100256048A1 (en) * 2007-10-29 2010-10-07 Astellas Pharma Inc. Polypeptide compound
US8034806B2 (en) 2007-11-02 2011-10-11 Vanderbilt University Bicyclic mGluR5 positive allosteric modulators and methods of making and using same
CN102076670B (zh) * 2008-06-24 2013-05-22 Irm责任有限公司 调节g蛋白偶联受体的化合物和方法
US9394340B2 (en) 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
BR112013023531A2 (pt) 2011-04-04 2016-12-06 Xellia Pharmaceuticals Aps processo de um único vaso para a fabricação de micafungina ou de um sal desta
RS54240B1 (en) 2011-04-20 2015-12-31 Xellia Pharmaceuticals Aps PROCEDURE FOR PURIFICATION OF MIKAFUNGIN
CN102775476B (zh) * 2011-05-12 2015-01-07 上海天伟生物制药有限公司 一种米卡芬净钠盐的制备方法
EP2709609B1 (fr) 2011-05-17 2017-10-04 Shionogi & Co., Ltd. Composés hétérocycliques
CN103917531B (zh) * 2011-09-09 2016-08-24 桑多斯股份公司 米卡芬净中间体的制备
CN102627689B (zh) * 2012-03-30 2014-08-06 上海天伟生物制药有限公司 一种环肽类化合物的水合物及其制备方法和用途
CN102659930B (zh) * 2012-03-30 2014-04-23 上海天伟生物制药有限公司 一种高纯度环肽类物质的晶体及其制备方法和用途
CN102627688B (zh) 2012-03-30 2014-12-31 上海天伟生物制药有限公司 一种高纯度环肽化合物及其制备方法和用途
US10183973B2 (en) * 2014-05-29 2019-01-22 Shanghai Techwell Biopharmaceutical Co., Ltd. Solvate of cyclic peptide compound, preparation method for same, and uses thereof
WO2016056023A2 (fr) * 2014-10-07 2016-04-14 Alaparthi Lakshmi Prasad Produits intermédiaires et procédés de préparation de micafungine
CA2937365C (fr) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Formulation en granules de 5-methyl-1-phenyl-2-(1h)-pyridone et methode de fabrication associee
EP3485873A1 (fr) 2017-11-17 2019-05-22 Cadila Healthcare Limited Compositions injectables pharmaceutiques stables de micafungine
CN113087775B (zh) * 2018-05-31 2022-07-08 杭州中美华东制药有限公司 米卡芬净钠新晶型ii及其制备方法
WO2020013116A1 (fr) * 2018-07-10 2020-01-16 京都薬品工業株式会社 Inhibiteur de ptp-1b et son utilisation
CN110734408A (zh) * 2019-10-22 2020-01-31 重庆康乐制药有限公司 一种米卡芬净类衍生物侧链中间体的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE912046A1 (en) * 1990-06-18 1991-12-18 Fujisawa Pharmaceutical Co New polypeptide compound and a process for preparation¹thereof
IL105048A (en) * 1992-03-19 2001-06-14 Eli Lilly And Company U S Antifungal substances of the cyclic peptide type and a process for their preparation

Also Published As

Publication number Publication date
OA10475A (en) 2002-04-08
DE69529172T2 (de) 2003-04-17
RU2165423C2 (ru) 2001-04-20
CN1168675A (zh) 1997-12-24
IL115484A (en) 2000-07-16
NO328483B1 (no) 2010-03-01
PT788511E (pt) 2003-04-30
HU228151B1 (en) 2012-12-28
AU3578095A (en) 1996-05-02
EP0788511A1 (fr) 1997-08-13
NO2010016I1 (no) 2010-08-16
ATE229541T1 (de) 2002-12-15
BR9504791A (pt) 1996-10-22
CA2202058C (fr) 2007-11-06
NO2010016I2 (no) 2011-10-17
AR041770A1 (es) 2005-06-01
WO1996011210A1 (fr) 1996-04-18
AU696949B2 (en) 1998-09-24
HUT77736A (hu) 1998-07-28
JP3518665B2 (ja) 2004-04-12
DK0788511T3 (da) 2003-03-31
ES2187575T3 (es) 2003-06-16
JP2897427B2 (ja) 1999-05-31
BR9504791B1 (pt) 2010-10-05
FR08C0028I2 (fr) 2009-11-20
FR08C0028I1 (fr) 2008-08-15
FI971397A (fi) 1997-05-27
DE69529172D1 (de) 2003-01-23
JPH10324695A (ja) 1998-12-08
LU91452I2 (fr) 2008-08-04
US6107458A (en) 2000-08-22
JPH10507174A (ja) 1998-07-14
TR199501229A2 (tr) 1996-07-21
US6265536B1 (en) 2001-07-24
NO971544D0 (no) 1997-04-04
IL115484A0 (en) 1996-01-19
HK1004136A1 (en) 1998-11-20
BRPI9504791B8 (pt) 2019-12-31
KR100353303B1 (ko) 2003-01-15
NL300352I1 (nl) 2008-08-01
NO971544L (no) 1997-06-04
KR970707150A (ko) 1997-12-01
FI971397A0 (fi) 1997-04-04
DE122008000025I1 (de) 2008-08-21
MX9702531A (es) 1997-06-28
CA2202058A1 (fr) 1996-04-18
DE122008000025I2 (de) 2011-02-17
CN1203089C (zh) 2005-05-25
EP0788511B1 (fr) 2002-12-11
NL300352I2 (nl) 2008-11-03

Similar Documents

Publication Publication Date Title
FI119988B (fi) Sykliset heksapeptidit, joilla on antibioottinen aktiivisuus
CA2044746C (fr) Compose peptideque et son processus de preparation
US5569646A (en) Polypeptide compound and a process for preparation thereof
US6232290B1 (en) Cyclic hexapeptides with antimicrobial activity
NZ511478A (en) Compounds useful in the treatment of inflammatory diseases
WO1993021215A1 (fr) Peptides ayant une action antagoniste de la tachykinine
JP2004526728A (ja) 抗菌活性を有する環状ヘキサペプチド化合物
JP3906690B2 (ja) 環状ヘキサペプチド誘導体
US6743776B2 (en) Cyclohexapeptides having antimicrobial activity
US5952299A (en) Cyclic peptide nuclei and derivatives thereof
JP2005524640A (ja) 新規化合物
US5654400A (en) Process for making peptide compounds having tachykinin antagonistic activity
USH1638H (en) Use of the polypeptide compound
AU2001234095B2 (en) Cyclic hexapeptide derivatives

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: ASTELLAS PHARMA INC.

Free format text: ASTELLAS PHARMA INC.

FG Patent granted

Ref document number: 119988

Country of ref document: FI

SPCF Supplementary protection certificate application filed

Free format text: SPC C20090038

Spc suppl protection certif: C20090038

SPCG Supplementary protection certificate granted

Spc suppl protection certif: 369

Extension date: 20200929

MA Patent expired